WUXI PHARMATECH INC ADS (NYSE: WX)





$15.65 -0.09 (-0.57%)
Real-time 12:00:00 AM ET
Turn On
KEY STATS
52-Week High Price
18.00
52-Week Low Price
3.67
Avg Volume (3 Mo.)
0.00 M
Market Cap
1.10 B
P/E Ratio (TTM)
15.2
Diluted EPS (TTM)
0.73
Shares
68.02 M
Dividend Rate ($) / (%)
0.00/0.00
69%
31%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 189% - WX has outperformed the S&P 500 by 163%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
IMMUCOR INC (BLUD) $18.70 -  $0.03(0.16%)1.29 B
MEDIVATION INC (MDVN) $36.53 -  $0.08(0.21%)1.24 B
WEST PHARMACEUTICAL SVCS (WST) $36.09 -  $0.58(1.63%)1.19 B
CUBIST PHARMACEUTICALS (CBST) $20.69 -  $0.76(3.81%)1.17 B
ACORDA THERAPEUTICS INC (ACOR) $30.15 -  $0.23(0.77%)1.17 B
ISIS PHARMACEUTICALS INC (ISIS) $11.02 -  $0.02(0.18%)1.09 B
ALKERMES INC (ALKS) $11.48 -  $0.11(0.97%)1.06 B
NEKTAR THERAPEUTIC SYSTS (NKTR) $11.71 -  $0.31(2.72%)1.06 B
MANNKIND CORPORATION (MNKD) $9.15 -  $0.16(1.80%)0.99 B
SEATTLE GENETICS INC (SGEN) $9.60 -  $0.26(2.73%)0.94 B
STOCK ANALYSIS
Stock Analysis
Biotech Bulls For July 14 (NVS)
AS the economy slows, money often pours into healthcare, biotech and big pharma. This week focuses on Novartis AG ADS.
WX RELATED HEADLINES
arrow
StockPreacher.com Issues Technical Trading Overview for WuXi PharmaTech (Cayman) Inc.
StockPreacher.com Issues Technical Trading Overview for WuXi PharmaTech (Cayman) Inc.

by GlobeNewswire 9/24/2009
arrow
WuXi PharmaTech (WX) NewsBite - WX Downgraded By Jefferies & Co.
WuXi PharmaTech (WX) was downgraded today by analysts at Jefferies & Co. and the stock is now at $7.56, down $0.42 (-5.26%) on volume of 1,094,851 shares traded. The brokerage reduced the stock to Underperform from Hold. Over the last 52 weeks the stock has ranged from a low of $3.67 to a high of $23.11. WuXi PharmaTech stock has been showing support around $...

At Market Intelligence Center 5/18/2009
arrow
Gurus Take A Shine To Gold
The best-performing online investors commit to the yellow metal.

Forbes.com 12/2/2008
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1